QRVO · As filed with the SEC
Qorvo cash flow statement, by quarter
The statement as Qorvo presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Consolidated Statements of Cash Flows (Unaudited) · USD thousands
| USD thousands | Q1 FY27 3 months ended Jun 27, 2026 | Q4 FY26† 3 months ended Mar 28, 2026 | Q3 FY26† 3 months ended Dec 27, 2025 | Q2 FY26† 3 months ended Sep 27, 2025 | Q1 FY26 3 months ended Jun 28, 2025 | Q4 FY25† 3 months ended Mar 29, 2025 | Q3 FY25† 3 months ended Dec 28, 2024 | Q2 FY25† 3 months ended Sep 28, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||
| Net income | 85,802 | 29,730† | 164,062† | 119,603† | 25,594 | 31,365† | 41,271† | (17,435)† |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Depreciation | 34,912 | 35,852† | 37,228† | 38,792† | 39,466 | 40,310† | 41,345† | 40,288† |
| Amortization of intangible assets | 15,225 | 26,852† | 28,292† | 27,913† | 27,994 | 30,468† | 32,482† | 35,793† |
| Deferred income taxes | (8,758) | (14,580)† | (12,937)† | (8,111)† | (3,756) | (21,469)† | (15,815)† | (21,849)† |
| Intangible Asset, Including Goodwill, Impairment Loss | — | 82,369† | 0† | — | — | 79,503† | 0† | — |
| Goodwill, Impairment Loss | — | — | — | — | — | — | 0† | — |
| Share-based Payment Arrangement, Noncash Expense | 34,411 | 26,321† | 26,849† | 40,425† | 42,475 | 27,415† | 28,384† | 38,181† |
| Other, net | 2,666 | 3,235† | (16,129)† | 1,277† | (1,804) | (31,499)† | 39,217† | 35,289† |
| Changes in operating assets and liabilities: | ||||||||
| Increase (Decrease) in Accounts Receivable | (2,941) | 104,995† | 54,964† | (98,600)† | 58,205 | 43,256† | 151,764† | (156,576)† |
| Increase (Decrease) in Inventories | 39,000 | (24,428)† | 73,196† | 42,573† | 4,725 | 14,369† | 1,269† | 16,912† |
| Increase (Decrease) in Prepaid Expense and Other Assets | (15,538) | (2,077)† | (17,352)† | 3,308† | 2,389 | 6,162† | (8,474)† | (19,238)† |
| Accounts payable and accrued liabilities | (13,007) | — | (90,401)† | 37,090† | (2,881) | — | (101,252)† | 63,734† |
| Income taxes payable and receivable | 4,672 | 6,191† | 12,170† | (3,226)† | (14,193) | 7,655† | (5,024)† | 15,854† |
| Other liabilities | 4,091 | (4,177)† | 5,490† | 13,584† | 4,731 | (13,859)† | 25,529† | 435† |
| Net cash provided by operating activities | 139,493 | 276,264† | 265,432† | 83,990† | 182,945 | 199,183† | 214,088† | 127,846† |
| Cash flows from investing activities: | ||||||||
| Payments to Acquire Property, Plant, and Equipment | 24,144 | (21,235)† | (28,495)† | (116,883)† | (37,543) | (28,513)† | (37,843)† | (33,012)† |
| Proceeds from sales of property and equipment | — | — | — | — | — | 4,663† | 982† | 1,297† |
| Proceeds from Divestiture of Businesses | — | — | 21,472† | 0† | 0 | — | 0† | 0† |
| Other investing activities | 1,298 | (12,342)† | 11,299† | 9,118† | 4,212 | 343† | 28,373† | (3,227)† |
| Net cash used in investing activities | (22,846) | 18,134† | 4,276† | (32,679)† | (33,331) | 95,639† | (7,074)† | (34,825)† |
| Cash flows from financing activities: | ||||||||
| Repurchase of common stock, including transaction costs | 0 | (400,050)† | (17,462)† | (65,134)† | (49,906) | (49,981)† | (100,015)† | (81,412)† |
| Proceeds from the issuance of common stock | 8,731 | 10,403† | 3,592† | 11,664† | 9,833 | 11,336† | 3,348† | 11,546† |
| Tax withholding paid on behalf of employees for restricted stock units | (10,272) | (2,863)† | (566)† | (21,299)† | (7,290) | (705)† | (994)† | (22,286)† |
| Repayments of Debt | — | — | 0† | 0† | 0 | — | 412,463† | 0† |
| Purchase and supply commitment, Supplies Proceeds | — | — | (30,631)† | (34,046)† | 45,599 | 897† | (13,497)† | 15,780† |
| Purchase (proceeds) for inventory supply commitment | (139) | — | — | — | — | — | — | — |
| Other financing activities | (4,787) | (6,934)† | (9,129)† | (4,503)† | (5,171) | (4,968)† | (8,064)† | (3,359)† |
| Net cash used in financing activities | (6,467) | (392,077)† | (54,196)† | (113,318)† | (6,935) | (43,421)† | (531,685)† | (79,731)† |
| Effect of exchange rate changes on cash and cash equivalents | (252) | (1,816)† | (287)† | (186)† | 1,623 | 343† | (2,349)† | 747† |
| Net increase in cash and cash equivalents | 109,928 | (99,495)† | 215,225† | (62,193)† | 144,302 | 251,744† | (327,020)† | 14,037† |
| Cash and cash equivalents at the beginning of the period | 1,219,015 | 1,318,510 | 1,103,285 | 1,165,478 | 1,021,176 | 769,432 | 1,096,452 | 1,082,415 |
| Cash and cash equivalents at the end of the period | 1,328,943 | 1,219,015 | 1,318,510 | 1,103,285 | 1,165,478 | 1,021,176 | 769,432 | 1,096,452 |
| Capital expenditures included in liabilities | 18,172 | (2,436)† | (13,573)† | (13,917)† | 54,666 | 2,117† | (9,927)† | 14,114† |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.